+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Atrial Fibrillation Market - Global Forecast 2025-2030- Product Image
Atrial Fibrillation Market - Global Forecast 2025-2030- Product Image
Sale

Atrial Fibrillation Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 188 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 4858006
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Atrial Fibrillation Market is positioned for multi-dimensional growth, propelled by ongoing advancements in clinical management, device innovation, and evolving international healthcare policies. Senior decision-makers are navigating complex stakeholder demands, technology trends, and regulatory updates that reshape risk and opportunity across the sector.

Market Snapshot: Atrial Fibrillation Market Size and Outlook

The global atrial fibrillation market grew from USD 10.75 billion in 2024 to USD 12.26 billion in 2025. It is projected to advance at a CAGR of 13.76%, reaching USD 23.31 billion by 2030. This reflects robust sector expansion driven by evolving patient needs, medical device innovations, and changes in reimbursement models.

Scope & Segmentation

This analysis delivers an in-depth perspective by examining the market across key categories and regions.

  • Treatment Types: Nonpharmacological therapies such as catheter ablation, device closure, and surgical ablation, alongside pharmacological interventions including antiarrhythmic drugs, anticoagulant drugs, and rate control agents.
  • Device Types: Ablation catheters, closure devices, cryoablation systems, mapping systems, and RF ablation systems.
  • Indications: Paroxysmal, permanent, and persistent atrial fibrillation categories guiding tailored interventions.
  • End Users: Ambulatory surgical centers, clinics, and hospitals leveraging patient-specific care delivery.
  • Distribution Channels: Hospital pharmacy, online pharmacy, and retail pharmacy pathways shaping patient access to treatments.
  • Age Groups: Segmentation includes patients aged 18 to 40, 41 to 60, and those above 61, recognizing distinct adherence and management challenges.
  • Regions: Americas (including the United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (from Western Europe to emerging Middle East markets), and Asia-Pacific (covering China, India, Japan, Australia, and other key economies).
  • Key Companies: Coverage includes AtriCure, Kardium, Abbott Laboratories, Biosense Webster, Medtronic, Boston Scientific, InCarda Therapeutics, Volta Medical, Field Medical, and OMEICOS Therapeutics among others.
  • Technologies: Artificial intelligence-powered mapping, cryoablation, digital remote monitoring, and bioabsorbable materials are all under analysis for their impact on future care pathways.

Atrial Fibrillation Market: Key Takeaways

  • Personalized approaches are gaining traction, aligning device and drug selections with evolving patient risk profiles and specific clinical indications.
  • Digital health and artificial intelligence solutions are transforming early detection, risk stratification, and real-time intervention for arrhythmia management.
  • Value-based care models are shifting provider priorities toward clinical outcomes and cost efficiency, influencing procurement and reimbursement strategies.
  • The competitive landscape is being redefined by mergers, pipeline innovation, and partnerships, with a focus on integrating pharmaceuticals, devices, and digital health platforms.
  • Market adoption differs by region, requiring tailored strategies that account for local infrastructure, policy barriers, and specific demographic trends.

Tariff Impact: U.S. Regulatory Decisions and Supply Chain Dynamics

In 2025, United States tariffs on medical device components significantly affected supply chain resilience and operational costs across the atrial fibrillation ecosystem. Manufacturers adapted by recalibrating sourcing strategies, prioritizing contract negotiations, and investing in new supply chain models. Healthcare providers responded by reviewing device selection criteria and exploring alternative technologies to maintain quality of care within budgetary constraints. This tariff environment spurred innovation in modular design, strengthened collaboration among suppliers, and increased overall cost transparency throughout procurement channels.

Methodology & Data Sources

The research framework integrates comprehensive literature analysis, expert interviews, and data harmonization across clinical and market endpoints. Insights were gathered from peer-reviewed publications, regulatory filings, and leading stakeholders in cardiology and procurement, with findings cross-validated to uphold analytical consistency.

Why This Report Matters

  • Equips senior leaders with a holistic understanding of market strategies, segmentation, and regional nuances in atrial fibrillation management.
  • Enables proactive resource allocation and investment by anticipating clinical, technological, and policy-driven shifts.
  • Offers actionable intelligence to optimize care delivery, foster innovation, and strengthen competitive positioning amid fast-changing reimbursement and supply chain landscapes.

Conclusion

The atrial fibrillation market is evolving toward integrated, technology-enabled models that prioritize personalized care, operational agility, and data-driven decision-making. Strategic collaboration and ongoing adaptation will distinguish organizations positioned for enduring success in this dynamic space.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Emergence of AI-driven risk stratification tools improving atrial fibrillation prognosis
5.2. Integration of telehealth services with remote ECG monitoring for atrial fibrillation management
5.3. Shift toward personalized anticoagulation therapies based on genetic and biomarker profiling
5.4. Increasing investments in catheter ablation technologies with novel energy delivery methods
5.5. Development of combination drug regimens targeting inflammatory pathways in atrial fibrillation
5.6. Expansion of digital therapeutics platforms offering lifestyle coaching for atrial fibrillation patients
5.7. Growing focus on early detection through mobile ECG patches in community health settings
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Atrial Fibrillation Market, by Treatment Type
8.1. Introduction
8.2. Nonpharmacological Treatment
8.2.1. Catheter Ablation
8.2.2. Device Closure
8.2.3. Surgical Ablation
8.3. Pharmacological Treatment
8.3.1. Antiarrhythmic Drugs
8.3.2. Anticoagulant Drugs
8.3.3. Rate Control Agents
9. Atrial Fibrillation Market, by Device Type
9.1. Introduction
9.2. Ablation Catheters
9.3. Closure Devices
9.4. Cryoablation Systems
9.5. Mapping Systems
9.6. RF Ablation Systems
10. Atrial Fibrillation Market, by Indication
10.1. Introduction
10.2. Paroxysmal
10.3. Permanent
10.4. Persistent
11. Atrial Fibrillation Market, by End User
11.1. Introduction
11.2. Ambulatory Surgical Centers
11.3. Clinics
11.4. Hospitals
12. Atrial Fibrillation Market, by Distribution Channel
12.1. Introduction
12.2. Hospital Pharmacy
12.3. Online Pharmacy
12.4. Retail Pharmacy
13. Atrial Fibrillation Market, by Age Group
13.1. Introduction
13.2. 18 To 40
13.3. 41 To 60
13.4. Above 61
14. Americas Atrial Fibrillation Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa Atrial Fibrillation Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific Atrial Fibrillation Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. AtriCure, Inc.
17.3.2. Kardium Inc.
17.3.3. Abbott Laboratories
17.3.4. Biosense Webster, Inc.
17.3.5. Medtronic plc
17.3.6. Boston Scientific Corporation
17.3.7. InCarda Therapeutics, Inc.
17.3.8. Volta Medical
17.3.9. Field Medical, Inc.
17.3.10. OMEICOS Therapeutics GmbH
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. ATRIAL FIBRILLATION MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY TREATMENT TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY TREATMENT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY DEVICE TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY DEVICE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY INDICATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY INDICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 14. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY AGE GROUP, 2024 VS 2030 (%)
FIGURE 16. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY AGE GROUP, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS ATRIAL FIBRILLATION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS ATRIAL FIBRILLATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES ATRIAL FIBRILLATION MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES ATRIAL FIBRILLATION MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA ATRIAL FIBRILLATION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA ATRIAL FIBRILLATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC ATRIAL FIBRILLATION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC ATRIAL FIBRILLATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. ATRIAL FIBRILLATION MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. ATRIAL FIBRILLATION MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 27. ATRIAL FIBRILLATION MARKET: RESEARCHAI
FIGURE 28. ATRIAL FIBRILLATION MARKET: RESEARCHSTATISTICS
FIGURE 29. ATRIAL FIBRILLATION MARKET: RESEARCHCONTACTS
FIGURE 30. ATRIAL FIBRILLATION MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. ATRIAL FIBRILLATION MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY NONPHARMACOLOGICAL TREATMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY NONPHARMACOLOGICAL TREATMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY CATHETER ABLATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY CATHETER ABLATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY DEVICE CLOSURE, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY DEVICE CLOSURE, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY SURGICAL ABLATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY SURGICAL ABLATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY NONPHARMACOLOGICAL TREATMENT, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY NONPHARMACOLOGICAL TREATMENT, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY PHARMACOLOGICAL TREATMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY PHARMACOLOGICAL TREATMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY ANTIARRHYTHMIC DRUGS, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY ANTIARRHYTHMIC DRUGS, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY ANTICOAGULANT DRUGS, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY ANTICOAGULANT DRUGS, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY RATE CONTROL AGENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY RATE CONTROL AGENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY PHARMACOLOGICAL TREATMENT, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY PHARMACOLOGICAL TREATMENT, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY DEVICE TYPE, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY ABLATION CATHETERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY ABLATION CATHETERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY CLOSURE DEVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY CLOSURE DEVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY CRYOABLATION SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY CRYOABLATION SYSTEMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY MAPPING SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY MAPPING SYSTEMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY RF ABLATION SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY RF ABLATION SYSTEMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY PAROXYSMAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY PAROXYSMAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY PERMANENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY PERMANENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY PERSISTENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY PERSISTENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY 18 TO 40, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY 18 TO 40, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY 41 TO 60, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY 41 TO 60, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY ABOVE 61, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY ABOVE 61, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. AMERICAS ATRIAL FIBRILLATION MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 76. AMERICAS ATRIAL FIBRILLATION MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 77. AMERICAS ATRIAL FIBRILLATION MARKET SIZE, BY NONPHARMACOLOGICAL TREATMENT, 2018-2024 (USD MILLION)
TABLE 78. AMERICAS ATRIAL FIBRILLATION MARKET SIZE, BY NONPHARMACOLOGICAL TREATMENT, 2025-2030 (USD MILLION)
TABLE 79. AMERICAS ATRIAL FIBRILLATION MARKET SIZE, BY PHARMACOLOGICAL TREATMENT, 2018-2024 (USD MILLION)
TABLE 80. AMERICAS ATRIAL FIBRILLATION MARKET SIZE, BY PHARMACOLOGICAL TREATMENT, 2025-2030 (USD MILLION)
TABLE 81. AMERICAS ATRIAL FIBRILLATION MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
TABLE 82. AMERICAS ATRIAL FIBRILLATION MARKET SIZE, BY DEVICE TYPE, 2025-2030 (USD MILLION)
TABLE 83. AMERICAS ATRIAL FIBRILLATION MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 84. AMERICAS ATRIAL FIBRILLATION MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 85. AMERICAS ATRIAL FIBRILLATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 86. AMERICAS ATRIAL FIBRILLATION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 87. AMERICAS ATRIAL FIBRILLATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 88. AMERICAS ATRIAL FIBRILLATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 89. AMERICAS ATRIAL FIBRILLATION MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 90. AMERICAS ATRIAL FIBRILLATION MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 91. AMERICAS ATRIAL FIBRILLATION MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 92. AMERICAS ATRIAL FIBRILLATION MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 93. UNITED STATES ATRIAL FIBRILLATION MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 94. UNITED STATES ATRIAL FIBRILLATION MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 95. UNITED STATES ATRIAL FIBRILLATION MARKET SIZE, BY NONPHARMACOLOGICAL TREATMENT, 2018-2024 (USD MILLION)
TABLE 96. UNITED STATES ATRIAL FIBRILLATION MARKET SIZE, BY NONPHARMACOLOGICAL TREATMENT, 2025-2030 (USD MILLION)
TABLE 97. UNITED STATES ATRIAL FIBRILLATION MARKET SIZE, BY PHARMACOLOGICAL TREATMENT, 2018-2024 (USD MILLION)
TABLE 98. UNITED STATES ATRIAL FIBRILLATION MARKET SIZE, BY PHARMACOLOGICAL TREATMENT, 2025-2030 (USD MILLION)
TABLE 99. UNITED STATES ATRIAL FIBRILLATION MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
TABLE 100. UNITED STATES ATRIAL FIBRILLATION MARKET SIZE, BY DEVICE TYPE, 2025-2030 (USD MILLION)
TABLE 101. UNITED STATES ATRIAL FIBRILLATION MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 102. UNITED STATES ATRIAL FIBRILLATION MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 103. UNITED STATES ATRIAL FIBRILLATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 104. UNITED STATES ATRIAL FIBRILLATION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 105. UNITED STATES ATRIAL FIBRILLATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 106. UNITED STATES ATRIAL FIBRILLATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 107. UNITED STATES ATRIAL FIBRILLATION MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 108. UNITED STATES ATRIAL FIBRILLATION MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 109. UNITED STATES ATRIAL FIBRILLATION MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 110. UNITED STATES ATRIAL FIBRILLATION MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 111. CANADA ATRIAL FIBRILLATION MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 112. CANADA ATRIAL FIBRILLATION MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 113. CANADA ATRIAL FIBRILLATION MARKET SIZE, BY NONPHARMACOLOGICAL TREATMENT, 2018-2024 (USD MILLION)
TABLE 114. CANADA ATRIAL FIBRILLATION MARKET SIZE, BY NONPHARMACOLOGICAL TREATMENT, 2025-2030 (USD MILLION)
TABLE 115. CANADA ATRIAL FIBRILLATION MARKET SIZE, BY PHARMACOLOGICAL TREATMENT, 2018-2024 (USD MILLION)
TABLE 116. CANADA ATRIAL FIBRILLATION MARKET SIZE, BY PHARMACOLOGICAL TREATMENT, 2025-2030 (USD MILLION)
TABLE 117. CANADA ATRIAL FIBRILLATION MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
TABLE 118. CANADA ATRIAL FIBRILLATION MARKET SIZE, BY DEVICE TYPE, 2025-2030 (USD MILLION)
TABLE 119. CANADA ATRIAL FIBRILLATION MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 120. CANADA ATRIAL FIBRILLATION MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 121. CANADA ATRIAL FIBRILLATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 122. CANADA ATRIAL FIBRILLATION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 123. CANADA ATRIAL FIBRILLATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 124. CANADA ATRIAL FIBRILLATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 125. CANADA ATRIAL FIBRILLATION MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 126. CANADA ATRIAL FIBRILLATION MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 127. MEXICO ATRIAL FIBRILLATION MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 128. MEXICO ATRIAL FIBRILLATION MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 129. MEXICO ATRIAL FIBRILLATION MARKET SIZE, BY NONPHARMACOLOGICAL TREATMENT, 2018-2024 (USD MILLION)
TABLE 130. MEXICO ATRIAL FIBRILLATION MARKET SIZE, BY NONPHARMACOLOGICAL TREATMENT, 2025-2030 (USD MILLION)
TABLE 131. MEXICO ATRIAL FIBRILLATION MARKET SIZE, BY PHARMACOLOGICAL TREATMENT, 2018-2024 (USD MILLION)
TABLE 132. MEXICO ATRIAL FIBRILLATION MARKET SIZE, BY PHARMACOLOGICAL TREATMENT, 2025-2030 (USD MILLION)
TABLE 133. MEXICO ATRIAL FIBRILLATION MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
TABLE 134. MEXICO ATRIAL FIBRILLATION MARKET SIZE, BY DEVICE TYPE, 2025-2030 (USD MILLION)
TABLE 135. MEXICO ATRIAL FIBRILLATION MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 136. MEXICO ATRIAL FIBRILLATION MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 137. MEXICO ATRIAL FIBRILLATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 138. MEXICO ATRIAL FIBRILLATION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 139. MEXICO ATRIAL FIBRILLATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 140. MEXICO ATRIAL FIBRILLATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 141. MEXICO ATRIAL FIBRILLATION MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 142. MEXICO ATRIAL FIBRILLATION MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 143. BRAZIL ATRIAL FIBRILLATION MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 144. BRAZIL ATRIAL FIBRILLATION MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 145. BRAZIL ATRIAL FIBRILLATION MARKET SIZE, BY NONPHARMACOLOGICAL TREATMENT, 2018-2024 (USD MILLION)
TABLE 146. BRAZIL ATRIAL FIBRILLATION MARKET SIZE, BY NONPHARMACOLOGICAL TREATMENT, 2025-2030 (USD MILLION)
TABLE 147. BRAZIL ATRIAL FIBRILLATION MARKET SIZE, BY PHARMACOLOGICAL TREATMENT, 2018-2024 (USD MILLION)
TABLE 148. BRAZIL ATRIAL FIBRILLATION MARKET SIZE, BY PHARMACOLOGICAL TREATMENT, 2025-2030 (USD MILLION)
TABLE 149. BRAZIL ATRIAL FIBRILLATION MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
TABLE 150. BRAZIL ATRIAL FIBRILLATION MARKET SIZE, BY DEVICE TYPE, 2025-2030 (USD MILLION)
TABLE 151. BRAZIL ATRIAL FIBRILLATION MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 152. BRAZIL ATRIAL FIBRILLATION MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 153. BRAZIL ATRIAL FIBRILLATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 154. BRAZIL ATRIAL FIBRILLATION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 155. BRAZIL ATRIAL FIBRILLATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 156. BRAZIL ATRIAL FIBRILLATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 157. BRAZIL ATRIAL FIBRILLATION MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 158. BRAZIL ATRIAL FIBRILLATION MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 159. ARGENTINA ATRIAL FIBRILLATION MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 160. ARGENTINA ATRIAL FIBRILLATION MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 161. ARGENTINA ATRIAL FIBRILLATION MARKET SIZE, BY NONPHARMACOLOGICAL TREATMENT, 2018-2024 (USD MILLION)
TABLE 162. ARGENTINA ATRIAL FIBRILLATION MARKET SIZE, BY NONPHARMACOLOGICAL TREATMENT, 2025-2030 (USD MILLION)
TABLE 163. ARGENTINA ATRIAL FIBRILLATION MARKET SIZE, BY PHARMACOLOGICAL TREATMENT, 2018-2024 (USD MILLION)
TABLE 164. ARGENTINA ATRIAL FIBRILLATION MARKET SIZE, BY PHARMACOLOGICAL TREATMENT, 2025-2030 (USD MILLION)
TABLE 165. ARGENTINA ATRIAL FIBRILLATION MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
TABLE 166. ARGENTINA ATRIAL FIBRILLATION MARKET SIZE, BY DEVICE TYPE, 2025-2030 (USD MILLION)
TABLE 167. ARGENTINA ATRIAL FIBRILLATION MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 168. ARGENTINA ATRIAL FIBRILLATION MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 169. ARGENTINA ATRIAL FIBRILLATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 170. ARGENTINA ATRIAL FIBRILLATION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 171. ARGENTINA ATRIAL FIBRILLATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 172. ARGENTINA ATRIAL FIBRILLATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 173. ARGENTINA ATRIAL FIBRILLATION MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 174. ARGENTINA ATRIAL FIBRILLATION MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 175. EUROPE, MIDDLE EAST & AFRICA ATRIAL FIBRILLATION MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 176. EUROPE, MIDDLE EAST & AFRICA ATRIAL FIBRILLATION MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 177. EUROPE, MIDDLE EAST & AFRICA ATRIAL FIBRILLATION MARKET SIZE, BY NONPHARMACOLOGICAL TREATMENT, 2018-2024 (USD MILLION)
TABLE 178. EUROPE, MIDDLE EAST & AFRICA ATRIAL FIBRILLATION MARKET SIZE, BY NONPHARMACOLOGICAL TREATMENT, 2025-2030 (USD MILLION)
TABLE 179. EUROPE, MIDDLE EAST & AFRICA ATRIAL FIBRILLATION MARKET SIZE, BY PHARMACOLOGICAL TREATMENT, 2018-2024 (USD MILLION)
TABLE 180. EUROPE, MIDDLE EAST & AFRICA ATRIAL FIBRILLATION MARKET SIZE, BY PHARMACOLOGICAL TREATMENT, 2025-2030 (USD MILLION)
TABLE 181. EUROPE, MIDDLE EAST & AFRICA ATRIAL FIBRILLATION MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
TABLE 182. EUROPE, MIDDLE EAST & AFRICA ATRIAL FIBRILLATION MARKET SIZE, BY DEVICE TYPE, 2025-2030 (USD MILLION)
TABLE 183. EUROPE, MIDDLE EAST & AFRICA ATRIAL FIBRILLATION MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 184. EUROPE, MIDDLE EAST & AFRICA ATRIAL FIBRILLATION MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 185. EUROPE, MIDDLE EAST & AFRICA ATRIAL FIBRILLATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 186. EUROPE, MIDDLE EAST & AFRICA ATRIAL FIBRILLATION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 187. EUROPE, MIDDLE EAST & AFRICA ATRIAL FIBRILLATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 188. EUROPE, MIDDLE EAST & AFRICA ATRIAL FIBRILLATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 189. EUROPE, MIDDLE EAST & AFRICA ATRIAL FIBRILLATION MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 190. EUROPE, MIDDLE EAST & AFRICA ATRIAL FIBRILLATION MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 191. EUROPE, MIDDLE EAST & AFRICA ATRIAL FIBRILLATION MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 192. EUROPE, MIDDLE EAST & AFRICA ATRIAL FIBRILLATION MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 193. UNITED KINGDOM ATRIAL FIBRILLATION MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 194. UNITED KINGDOM ATRIAL FIBRILLATION MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 195. UNITED KINGDOM ATRIAL FIBRILLATION MARKET SIZE, BY NONPHARMACOLOGICAL TREATMENT, 2018-2024 (USD MILLION)
TABLE 196. UNITED KINGDOM ATRIAL FIBRILLATION MARKET SIZE, BY NONPHARMACOLOGICAL TREATMENT, 2025-2030 (USD MILLION)
TABLE 197. UNITED KINGDOM ATRIAL FIBRILLATION MARKET SIZE, BY PHARMACOLOGICAL TREATMENT, 2018-2024 (USD MILLION)
TABLE 198. UNITED KINGDOM ATRIAL FIBRILLATION MARKET SIZE, BY PHARMACOLOGICAL TREATMENT, 2025-2030 (USD MILLION)
TABLE 199. UNITED KINGDOM ATRIAL FIBRILLATION MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
TABLE 200. UNITED KINGDOM ATRIAL FIBRILLATION MARKET SIZE, BY DEVICE TYPE, 2025-2030 (USD MILLION)
TABLE 201. UNITED KINGDOM ATRIAL FIBRILLATION MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 202. UNITED KINGDOM ATRIAL FIBRILLATION MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 203. UNITED KINGDOM ATRIAL FIBRILLATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 204. UNITED KINGDOM ATRIAL FIBRILLATION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 205. UNITED KINGDOM ATRIAL FIBRILLATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 206. UNITED KINGDOM ATRIAL FIBRILLATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 207. UNITED KINGDOM ATRIAL FIBRILLATION MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 208. UNITED KINGDOM ATRIAL FIBRILLATION MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 209. GERMANY ATRIAL FIBRILLATION MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 210. GERMANY ATRIAL FIBRILLATION MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 211. GERMANY ATRIAL FIBRILLATION MARKET SIZE, BY NONPHARMACOLOGICAL TREATMENT, 2018-2024 (USD MILLION)
TABLE 212. GERMANY ATRIAL FIBRILLATION MARKET SIZE, BY NONPHARMACOLOGICAL TREATMENT, 2025-2030 (USD MILLION)
TABLE 213. GERMANY ATRIAL FIBRILLATION MARKET SIZE, BY PHARMACOLOGICAL TREATMENT, 2018-2024 (USD MILLION)
TABLE 214. GERMANY ATRIAL FIBRILLATION MARKET SIZE, BY PHARMACOLOGICAL TREATMENT, 2025-2030 (USD MILLION)
TABLE 215. GERMANY ATRIAL FIBRILLATION MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
TABLE 216. GERMANY ATRIAL FIBRILLATION MARKET SIZE, BY DEVICE TYPE, 2025-2030 (USD MILLION)
TABLE 217. GERMANY ATRIAL FIBRILLATION MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 218. GERMANY ATRIAL FIBRILLATION MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 219. GERMANY ATRIAL FIBRILLATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 220. GERMANY ATRIAL FIBRILLATION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 221. GERMANY ATRIAL FIBRILLATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 222. GERMANY ATRIAL FIBRILLATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 223. GERMANY ATRIAL FIBRILLATION MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 224. GERMANY ATRIAL FIBRILLATION MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 225. FRANCE ATRIAL FIBRILLATION MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 226. FRANCE ATRIAL FIBRILLATION MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 227. FRANCE ATRIAL FIBRILLATION MARKET SIZE, BY NONPHARMACOLOGICAL TREATMENT, 2018-2024 (USD MILLION)
TABLE 228. FRANCE ATRIAL FIBRILLATION MARKET SIZE, BY NONPHARMACOLOGICAL TREATMENT, 2025-2030 (USD MILLION)
TABLE 229. FRANCE ATRIAL FIBRILLATION MARKET SIZE, BY PHARMACOLOGICAL TREATMENT, 2018-2024 (USD MILLION)
TABLE 230. FRANCE ATRIAL FIBRILLATION MARKET SIZE, BY PHARMACOLOGICAL TREATMENT, 2025-2030 (USD MILLION)
TABLE 231. FRANCE ATRIAL FIBRILLATION MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
TABLE 232. FRANCE ATRIAL FIBRILLATION MARKET SIZE, BY DEVICE TYPE, 2025-2030 (USD MILLION)
TABLE 233. FRANCE ATRIAL FIBRILLATION MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 234. FRANCE ATRIAL FIBRILLATION MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 235. FRANCE ATRIAL FIBRILLATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 236. FRANCE ATRIAL FIBRILLATION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 237. FRANCE ATRIAL FIBRILLATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 238. FRANCE ATRIAL FIBRILLATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 239. FRANCE ATRIAL FIBRILLATION MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 240. FRANCE ATRIAL FIBRILLATION MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 241. RUSSIA ATRIAL FIBRILLATION MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 242. RUSSIA ATRIAL FIBRILLATION MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 243. RUSSIA ATRIAL FIBRILLATION MARKET SIZE, BY NONPHARMACOLOGICAL TREATMENT, 2018-2024 (USD MILLION)
TABLE 244. RUSSIA ATRIAL FIBRILLATION MARKET SIZE, BY NONPHARMACOLOGICAL TREATMENT, 2025-2030 (USD MILLION)
TABLE 245. RUSSIA ATRIAL FIBRILLATION MARKET SIZE, BY PHARMACOLOGICAL TREATMENT, 2018-2024 (USD MILLION)
TABLE 246. RUSSIA ATRIAL FIBRILLATION MARKET SIZE, BY PHARMACOLOGICAL TREATMENT, 2025-2030 (USD MILLION)
TABLE 247. RUSSIA ATRIAL FIBRILLATION MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
TABLE 248. RUSSIA ATRIAL FIBRILLATION MARKET SIZE, BY DEVICE TYPE, 2025-2030 (USD MILLION)
TABLE 249. RUSSIA ATRIAL FIBRILLATION MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 250. RUSSIA ATRIAL FIBRILLATION MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 251. RUSSIA ATRIAL FIBRILLATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 252. RUSSIA ATRIAL FIBRILLATION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 253. RUSSIA ATRIAL FIBRILLATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 254. RUSSIA ATRIAL FIBRILLATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 255. RUSSIA ATRIAL FIBRILLATION MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 256. RUSSIA ATRIAL FIBRILLATION MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 257. ITALY ATRIAL FIBRILLATION MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 258. ITALY ATRIAL FIBRILLATION MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 259. ITALY ATRIAL FIBRILLATION MARKET SIZE, BY NONPHARMACOLOGICAL TREATMENT, 2018-2024 (USD MILLION)
TABLE 260. ITALY ATRIAL FIBRILLATION MARKET SIZE, BY NONPHARMACOLOGICAL TREATMENT, 2025-2030 (USD MILLION)
TABLE 261. ITALY ATRIAL FIBRILLATION MARKET SIZE, BY PHARMACOLOGICAL TREATMENT, 2018-2024 (USD MILLION)
TABLE 262. ITALY ATRIAL FIBRILLATION MARKET SIZE, BY PHARMACOLOGICAL TREATMENT, 2025-2030 (USD MILLION)
TABLE 263. ITALY ATRIAL FIBRILLATION MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
TABLE 264. ITALY ATRIAL FIBRILLATION MARKET SIZE, BY DEVICE TYPE, 2025-2030 (USD MILLION)
TABLE 265. ITALY ATRIAL FIBRILLATION MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 266. ITALY ATRIAL FIBRILLATION MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 267. ITALY ATRIAL FIBRILLATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 268. ITALY ATRIAL FIBRILLATION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 269. ITALY ATRIAL FIBRILLATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 270. ITALY ATRIAL FIBRILLATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 271. ITALY ATRIAL FIBRILLATION MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 272. ITALY ATRIAL FIBRILLATION MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 273. SPAIN ATRIAL FIBRILLATION MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 274. SPAIN ATRIAL FIBRILLATION MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 275. SPAIN ATRIAL FIBRILLATION MARKET SIZE, BY NONPHARMACOLOGICAL TREATMENT, 2018-2024 (USD MILLION)
TABLE 276. SPAIN ATRIAL FIBRILLATION MARKET SIZE, BY NONPHARMACOLOGICAL TREATMENT, 2025-2030 (USD MILLION)
TABLE 277. SPAIN ATRIAL FIBRILLATION MARKET SIZE, BY PHARMACOLOGICAL TREATMENT, 2018-2024 (USD MILLION)
TABLE 278. SPAIN ATRIAL FIBRILLATION MARKET SIZE, BY PHARMACOLOGICAL TREATMENT, 2025-2030 (USD MILLION)
TABLE 279. SPAIN ATRIAL FIBRILLATION MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
TABLE 280. SPAIN ATRIAL FIBRILLATION MARKET SIZE, BY DEVICE TYPE, 2025-2030 (USD MILLION)
TABLE 281. SPAIN ATRIAL FIBRILLATION MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 282. SPAIN ATRIAL FIBRILLATION MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 283. SPAIN ATRIAL FIBRILLATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 284. SPAIN ATRIAL FIBRILLATION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 285. SPAIN ATRIAL FIBRILLATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 286. SPAIN ATRIAL FIBRILLATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 287. SPAIN ATRIAL FIBRILLATION MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 288. SPAIN ATRIAL FIBRILLATION MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 289. UNITED ARAB EMIRATES ATRIAL FIBRILLATION MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 290. UNITED ARAB EMIRATES ATRIAL FIBRILLATION MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 291. UNITED ARAB EMIRATES ATRIAL FIBRILLATION MARKET SIZE, BY NONPHARMACOLOGICAL TREATMENT, 2018-2024 (USD MILLION)
TABLE 292. UNITED ARAB EMIRATES ATRIAL FIBRILLATION MARKET SIZE, BY NONPHARMACOLOGICAL TREATMENT, 2025-2030 (USD MILLION)
TABLE 293. UNITED ARAB EMIRATES ATRIAL FIBRILLATION MARKET SIZE, BY PHARMACOLOGICAL TREATMENT, 2018-2024 (USD MILLION)
TABLE 294. UNITED ARAB EMIRATES ATRIAL FIBRILLATION MARKET SIZE, BY PHARMACOLOGICAL TREATMENT, 2025-2030 (USD MILLION)
TABLE 295. UNITED ARAB EMIRATES ATRIAL FIBRILLATION MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
TABLE 296. UNITED ARAB EMIRATES ATRIAL FIBRILLATION MARKET SIZE, BY DEVICE TYPE, 2025-2030 (USD MILLION)
TABLE 297. UNITED ARAB EMIRATES ATRIAL FIBRILLATION MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 298. UNITED ARAB EMIRATES ATRIAL FIBRILLATION MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 299. UNITED ARAB EMIRATES ATRIAL FIBRILLATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 300. UNITED ARAB EMIRATES ATRIAL FIBRILLATION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 301. UNITED ARAB EMIRATES ATRIAL FIBRILLATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 302. UNITED ARAB EMIRATES ATRIAL FIBRILLATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 303. UNITED ARAB EMIRATES ATRIAL FIBRILLATION MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 304. UNITED ARAB EMIRATES ATRIAL FIBRILLATION MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 305. SAUDI ARABIA ATRIAL FIBRILLATION MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 306. SAUDI ARABIA ATRIAL FIBRILLATION MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 307. SAUDI ARABIA ATRIAL FIBRILLATION MARKET SIZE, BY NONPHARMACOLOGICAL TREATMENT, 2018-2024 (USD MILLION)
TABLE 308. SAUDI ARABIA ATRIAL FIBRILLATION MARKET SIZE, BY NONPHARMACOLOGICAL TREATMENT, 2025-2030 (USD MILLION)
TABLE 309. SAUDI ARABIA ATRIAL FIBRILLATION MARKET SIZE, BY PHARMACOLOGICAL TREATMENT, 2018-2024 (USD MILLION)
TABLE 310. SAUDI ARABIA ATRIAL FIBRILLATION MARKET SIZE, BY PHARMACOLOGICAL TREATMENT, 2025-2030 (USD MILLION)
TABLE 311. SAUDI ARABIA ATRIAL FIBRILLATION MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
TABLE 312. SAUDI ARABIA ATRIAL FIBRILLATION MARKET SIZE, BY DEVICE TYPE, 2025-2030 (USD MILLION)
TABLE 313. SAUDI ARABIA ATRIAL FIBRILLATION MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 314. SAUDI ARABIA ATRIAL FIBRILLATION MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 315. SAUDI ARABIA ATRIAL FIBRILLATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 316. SAUDI ARABIA ATRIAL FIBRILLATION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 317. SAUDI ARABIA ATRIAL FIBRILLATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 318. SAUDI ARABIA ATRIAL FIBRILLATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 319. SAUDI ARABIA ATRIAL FIBRILLATION MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 320. SAUDI ARABIA ATRIAL FIBRILLATION MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 321. SOUTH AFRICA ATRIAL FIBRILLATION MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 322. SOUTH AFRICA ATRIAL FIBRILLATION MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 323. SOUTH AFRICA ATRIAL FIBRILLATION MARKET SIZE, BY NONPHARMACOLOGICAL TREATMENT, 2018-2024 (USD MILLION)
TABLE 324. SOUTH AFRICA ATRIAL FIBRILLATION MARKET SIZE, BY NONPHARMACOLOGICAL TREATMENT, 2025-2030 (USD MILLION)
TABLE 325. SOUTH AFRICA ATRIAL FIBRILLATION MARKET SIZE, BY PHARMACOLOGICAL TREATMENT, 2018-2024 (USD MILLION)
TABLE 326. SOUTH AFRICA ATRIAL FIBRILLATION MARKET SIZE, BY PHARMACOLOGICAL TREATMENT, 2025-2030 (USD MILLION)
TABLE 327. SOUTH AFRICA ATRIAL FIBRILLATION MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
TABLE 328. SOUTH AFRICA ATRIAL FIBRILLATION MARKET SIZE, BY DEVICE TYPE, 2025-2030 (USD MILLION)
TABLE 329. SOUTH AFRICA ATRIAL FIBRILLATION MARKET

Samples

Loading
LOADING...

Companies Mentioned

  • AtriCure, Inc.
  • Kardium Inc.
  • Abbott Laboratories
  • Biosense Webster, Inc.
  • Medtronic plc
  • Boston Scientific Corporation
  • InCarda Therapeutics, Inc.
  • Volta Medical
  • Field Medical, Inc.
  • OMEICOS Therapeutics GmbH

Table Information

Report AttributeDetails
No. of Pages188
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 12.26 Billion
Forecasted Market Value ( USD ) by 2030 $ 23.31 Billion
Compound Annual Growth Rate13.7%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

Atrial Fibrillation Surgery Market - Global Forecast 2025-2030 - Product Image

Atrial Fibrillation Surgery Market - Global Forecast 2025-2030

  • Report
  • 187 Pages
  • Global
From
Atrial Fibrillation Devices Market - Global Forecast 2025-2030 - Product Image

Atrial Fibrillation Devices Market - Global Forecast 2025-2030

  • Report
  • 184 Pages
  • Global
From
Atrial Fibrillation Market Report and Forecast 2025-2034 - Product Image

Atrial Fibrillation Market Report and Forecast 2025-2034

  • Report
  • 400 Pages
  • Global
From
Atrial Fibrillation Market Report 2025 - Product Image

Atrial Fibrillation Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Electrophysiology Devices - Global Strategic Business Report - Product Image

Electrophysiology Devices - Global Strategic Business Report

  • Report
  • 194 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.